APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease

This study aimed to evaluate the impact of APOE4 homozygosity on Alzheimer's disease (AD) by examining its clinical, pathological and biomarker changes to see whether APOE4 homozygotes constitute a distinct, genetically determined form of AD. Data from the National Alzheimer's Coordinating...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Nature medicine Ročník 30; číslo 5; s. 1284
Hlavní autori:	Fortea, Juan, Pegueroles, Jordi, Alcolea, Daniel, Belbin, Olivia, Dols-Icardo, Oriol, Vaqué-Alcázar, Lídia, Videla, Laura, Gispert, Juan Domingo, Suárez-Calvet, Marc, Johnson, Sterling C, Sperling, Reisa, Bejanin, Alexandre, Lleó, Alberto, Montal, Víctor
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.05.2024
Predmet:	Age of Onset Aged Aged, 80 and over Alzheimer Disease - cerebrospinal fluid Alzheimer Disease - diagnostic imaging Alzheimer Disease - genetics Alzheimer Disease - pathology Amyloid - genetics Amyloid - metabolism Amyloid beta-Peptides - cerebrospinal fluid Amyloid beta-Peptides - genetics Amyloid beta-Peptides - metabolism Apolipoprotein E3 - genetics Apolipoprotein E4 - genetics Biomarkers - cerebrospinal fluid Cohort Studies Female Homozygote Humans Male Middle Aged Positron-Emission Tomography tau Proteins - cerebrospinal fluid tau Proteins - genetics
ISSN:	1546-170X, 1546-170X
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!